Connect Biopharma (CNTB) Short Interest Ratio & Short Volume $2.04 +0.04 (+2.00%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$2.00 -0.04 (-1.96%) As of 08/4/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Connect Biopharma Short Interest DataConnect Biopharma (CNTB) has a short interest of 59,900 shares. This marks a 110.92% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 285,295 shares to cover all short positions.Current Short Interest59,900 sharesPrevious Short Interest28,400 sharesChange Vs. Previous Month+110.92%Dollar Volume Sold Short$87.45 thousandShort Interest Ratio0.4 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares55,560,000 sharesPercentage of Shares Shorted0.11%Today's Trading Volume129,318 sharesAverage Trading Volume285,295 sharesToday's Volume Vs. Average45% Short Selling Connect Biopharma? Sign up to receive the latest short interest report for Connect Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNTB Short Interest Over TimeCNTB Days to Cover Over TimeCNTB Percentage of Float Shorted Over Time Connect Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202559,900 shares $87.45 thousand +110.9%N/A0.4 $1.46 6/30/202528,400 shares $27.83 thousand +66.1%0.1%0.2 $0.98 6/15/202517,100 shares $16.25 thousand -72.2%0.0%0.1 $0.95 5/31/202561,400 shares $48.00 thousand -19.1%0.1%0.5 $0.78 5/15/202575,900 shares $55.18 thousand +56.5%0.2%0.7 $0.73 4/30/202548,500 shares $39.85 thousand -25.4%N/A0.5 $0.82 4/15/202565,000 shares $53.94 thousand +1,103.7%0.2%0.7 $0.83 3/31/20255,400 shares $2.97 thousand -47.6%0.0%0.1 $0.55 3/15/202510,300 shares $8.82 thousand -77.9%0.0%0.5 $0.86 2/28/202546,700 shares $42.17 thousand +56.7%0.1%1.9 $0.90 Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/202529,800 shares $27.49 thousand -4.8%0.1%1.2 $0.92 1/31/202531,300 shares $30.42 thousand -23.5%0.1%1.1 $0.97 1/15/202540,900 shares $42.95 thousand -44.6%0.1%1.5 $1.05 12/31/202473,800 shares $101.84 thousand -16.0%0.1%2.6 $1.38 12/15/202487,800 shares $98.20 thousand +53.5%0.2%3.1 $1.12 11/30/202457,200 shares $60.63 thousand -7.4%0.1%2.2 $1.06 11/15/202461,800 shares $68.60 thousand +110.2%0.1%2.1 $1.11 10/31/202429,400 shares $34.10 thousand -35.4%0.1%1 $1.16 10/15/202445,500 shares $57.33 thousand +26.7%0.1%1.7 $1.26 9/30/202435,900 shares $50.98 thousand +60.3%0.1%1.2 $1.42 9/15/202422,400 shares $27.55 thousand +5.2%0.0%0.5 $1.23 8/31/202421,300 shares $34.08 thousand +76.0%0.0%0.4 $1.60 8/15/202412,100 shares $13.79 thousand -9.7%0.0%0.2 $1.14 7/31/202413,400 shares $15.95 thousand +24.1%0.0%0.2 $1.19 7/15/202410,800 shares $13.61 thousand -30.3%0.0%0.2 $1.26 6/30/202415,500 shares $23.56 thousand -44.2%0.0%0.2 $1.52 6/15/202427,800 shares $44.48 thousand -21.5%0.1%0.2 $1.60 5/31/202435,400 shares $60.53 thousand -34.6%0.1%0.3 $1.71 5/15/202454,100 shares $99.00 thousand +73.4%0.1%0.3 $1.83 4/30/202431,200 shares $43.37 thousand -62.5%0.1%0.2 $1.39 4/15/202483,100 shares $138.78 thousand -28.1%0.2%0.5 $1.67 3/31/2024115,500 shares $200.97 thousand +7.5%0.2%0.7 $1.74 3/15/2024107,400 shares $139.62 thousand -13.2%0.2%0.8 $1.30 2/29/2024123,700 shares $141.02 thousand -2.7%0.2%0.4 $1.14 2/15/2024127,100 shares $153.79 thousand -34.8%0.2%0.4 $1.21 1/31/2024194,800 shares $227.92 thousand +52.8%0.4%0.5 $1.17 1/15/2024127,500 shares $140.86 thousand -21.3%0.2%0.3 $1.10 12/31/2023162,100 shares $191.28 thousand -59.8%0.3%0.4 $1.18 12/15/2023403,200 shares $380.54 thousand +208.3%0.8%1.1 $0.94 11/30/2023130,800 shares $150.42 thousand +476.2%0.3%0.6 $1.15Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now. 11/15/202322,700 shares $40.41 thousand -22.8%0.0%0.1 $1.78 10/31/202329,400 shares $43.22 thousand +88.5%0.1%0.5 $1.47 10/15/202315,600 shares $13.54 thousand -40.7%0.0%0.3 $0.87 9/30/202326,300 shares $21.54 thousand +250.7%0.1%0.6 $0.82 9/15/20237,500 shares $5.70 thousand -13.8%0.0%0.2 $0.76 8/31/20238,700 shares $7.18 thousand -61.5%0.0%0.2 $0.83 8/15/202322,600 shares $20.36 thousand -48.3%0.0%0.1 $0.90 7/31/202343,700 shares $42.39 thousand +55.5%0.1%0.1 $0.97 7/15/202328,100 shares $30.35 thousand -52.5%0.1%0.1 $1.08 6/30/202359,200 shares $66.90 thousand -19.8%0.1%0.2 $1.13 6/15/202373,800 shares $74.54 thousand -12.3%0.1%0.2 $1.01 5/31/202384,100 shares $91.15 thousand +14.3%0.2%0.1 $1.08 5/15/202373,600 shares $91.26 thousand -23.1%0.1%0.2 $1.24 4/30/202395,700 shares $101.92 thousand -25.8%0.2%0.3 $1.07 4/15/2023128,900 shares $135.35 thousand -14.1%0.2%0.4 $1.05 3/31/2023150,000 shares $149.99 thousand +100.8%0.3%0.5 $1.00 3/15/202374,700 shares $83.66 thousand -12.2%0.1%0.2 $1.12 2/28/202385,100 shares $109.78 thousand -15.0%0.2%1.6 $1.29 2/15/2023100,100 shares $103.10 thousand -11.0%0.2%2 $1.03 1/31/2023112,500 shares $138.38 thousand -3.5%0.2%2.3 $1.23 1/15/2023116,600 shares $115.32 thousand -12.5%0.2%2.3 $0.99 12/30/2022133,200 shares $115.59 thousand -58.0%0.3%2.4 $0.87 12/15/2022316,800 shares $275.62 thousand -1.2%0.6%2.8 $0.87 11/30/2022320,600 shares $232.53 thousand -4.0%0.6%2.8 $0.73 11/15/2022334,000 shares $251.20 thousand -8.2%0.6%2.5 $0.75 10/31/2022364,000 shares $316.61 thousand -32.0%0.7%2.1 $0.87 10/15/2022535,000 shares $506.00 thousand +29.9%1.0%1.7 $0.95 9/30/2022411,900 shares $531.35 thousand +2.6%0.8%1.3 $1.29 9/15/2022401,400 shares $586.04 thousand -15.7%0.8%1.1 $1.46 8/31/2022476,400 shares $666.96 thousand -2.2%0.9%1.2 $1.40 8/15/2022487,100 shares $706.30 thousand +1.1%0.9%1.2 $1.45 7/31/2022481,600 shares $392.60 thousand +7.6%0.9%1.1 $0.82 7/15/2022447,600 shares $407.32 thousand +124.8%0.8%1.1 $0.91 6/30/2022199,100 shares $173.22 thousand +7.4%0.4%0.5 $0.87 6/15/2022185,400 shares $133.99 thousand -18.0%0.4%0.7 $0.72 5/31/2022226,000 shares $180.80 thousand +23.4%N/A0.9 $0.80 5/15/2022183,100 shares $137.33 thousand -42.5%N/A0.7 $0.75 4/30/2022318,400 shares $646.35 thousand +5.5%N/A1.7 $2.03 4/15/2022301,900 shares $863.43 thousand +6.0%N/A3.5 $2.86 3/31/2022284,900 shares $860.40 thousand +8.6%N/A2.3 $3.02 3/15/2022262,400 shares $645.50 thousand +2.3%N/A1.1 $2.46 2/28/2022256,500 shares $1.01 million +7.1%N/A0.9 $3.92 2/15/2022239,600 shares $1.08 million -24.3%N/A0.7 $4.50 1/31/2022316,600 shares $1.46 million -7.5%0.6%0.7 $4.60 1/15/2022342,400 shares $1.76 million +25.7%N/A0.7 $5.14 12/31/2021272,400 shares $1.40 million +3.6%N/A0.6 $5.15 12/15/2021263,000 shares $1.22 million +533.7%N/A0.8 $4.64 11/30/202141,500 shares $180.53 thousand -97.7%N/A0.1 $4.35 11/15/20211,810,000 shares $23.57 million +30.2%N/A7.4 $13.02 10/29/20211,390,000 shares $22.02 million +36.3%N/A15.3 $15.84Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now. 10/15/20211,020,000 shares $17.51 million +19.3%N/A13.9 $17.17 9/30/2021855,200 shares $20.72 million +0.1%N/A15.6 $24.23 9/15/2021854,600 shares $18.23 million +0.3%N/A14.2 $21.33 8/31/2021851,700 shares $19.99 million +0.6%N/A13.6 $23.47 8/13/2021846,300 shares $19.90 million No ChangeN/A14.1 $23.51 CNTB Short Interest - Frequently Asked Questions What is Connect Biopharma's current short interest? Short interest is the volume of Connect Biopharma shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 59,900 shares of CNTB short. Learn More on Connect Biopharma's current short interest. Is Connect Biopharma's short interest increasing or decreasing? Connect Biopharma saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 59,900 shares, an increase of 110.9% from the previous total of 28,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Connect Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Connect Biopharma: Gossamer Bio, Inc. (7.97%), Compass Therapeutics, Inc. (8.91%), REGENXBIO Inc. (12.32%), Kamada Ltd. (0.30%), Kodiak Sciences Inc. (5.12%), Tectonic Therapeutic, Inc. (18.11%), Fulcrum Therapeutics, Inc. (9.10%), COMPASS Pathways PLC Sponsored ADR (9.38%), Eton Pharmaceuticals, Inc. (13.30%), Aquestive Therapeutics, Inc. (10.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Connect Biopharma stock? Short selling CNTB is an investing strategy that aims to generate trading profit from Connect Biopharma as its price is falling. CNTB shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Connect Biopharma? A short squeeze for Connect Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTB, which in turn drives the price of the stock up even further. How often is Connect Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTB, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies GOSS Short Interest CMPX Short Interest RGNX Short Interest KMDA Short Interest KOD Short Interest TECX Short Interest FULC Short Interest CMPS Short Interest ETON Short Interest AQST Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNTB) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNTB Stock Alerts